xCures Raises $46 Million Series B to Expand Clinical Clarity Platform

Jun 25, 2026
xCures has raised $46 million in Series B funding led by Innovius Capital. The financing will support the expansion of its platform that converts fragmented medical records into structured clinical data.

xCures has closed a $46 million Series B financing round led by Innovius Capital, with participation from iGrow, GKCC, Spring Mountain Capital, and existing investors, announced in a press release. The new funding brings the company's total capital raised to more than $76 million.

The investment will be used to expand xCures' Clinical Clarity Engine, which transforms fragmented medical records into structured, decision ready clinical data. The company has processed over 300 million medical records from more than 550,000 healthcare locations across the United States, supporting clinical decision making for millions of patients.

xCures CEO Mika Newton said the funding will accelerate product development, expand the team, and help more organizations convert unstructured records into actionable information.

We hope you enjoyed this article

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.